Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 265

1.

Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient mice.

Chrzanowska-Wodnicka M, Kraus AE, Gale D, White GC 2nd, Vansluys J.

Blood. 2008 Mar 1;111(5):2647-56. Epub 2007 Nov 9.

2.

Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling.

Awasthi N, Schwarz MA, Verma V, Cappiello C, Schwarz RE.

Lab Invest. 2009 Jan;89(1):38-46. doi: 10.1038/labinvest.2008.106. Epub 2008 Nov 10.

3.

Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.

Lovren F, Pan Y, Shukla PC, Quan A, Teoh H, Szmitko PE, Peterson MD, Gupta M, Al-Omran M, Verma S.

Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1440-9. doi: 10.1152/ajpendo.90780.2008. Epub 2009 Apr 7.

4.

Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.

Ryu J, Lee CW, Hong KH, Shin JA, Lim SH, Park CS, Shim J, Nam KB, Choi KJ, Kim YH, Han KH.

Cardiovasc Res. 2008 May 1;78(2):333-40. Epub 2007 Nov 11.

PMID:
18006432
5.

Rap1a is a key regulator of fibroblast growth factor 2-induced angiogenesis and together with Rap1b controls human endothelial cell functions.

Yan J, Li F, Ingram DA, Quilliam LA.

Mol Cell Biol. 2008 Sep;28(18):5803-10. doi: 10.1128/MCB.00393-08. Epub 2008 Jul 14.

6.

VEGF189 stimulates endothelial cells proliferation and migration in vitro and up-regulates the expression of Flk-1/KDR mRNA.

Hervé MA, Buteau-Lozano H, Mourah S, Calvo F, Perrot-Applanat M.

Exp Cell Res. 2005 Sep 10;309(1):24-31.

PMID:
15996656
7.

VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression.

Liu Z, Kobayashi K, van Dinther M, van Heiningen SH, Valdimarsdottir G, van Laar T, Scharpfenecker M, Löwik CW, Goumans MJ, Ten Dijke P, Pardali E.

J Cell Sci. 2009 Sep 15;122(Pt 18):3294-302. doi: 10.1242/jcs.048942. Epub 2009 Aug 25.

8.

EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.

Brantley-Sieders DM, Caughron J, Hicks D, Pozzi A, Ruiz JC, Chen J.

J Cell Sci. 2004 Apr 15;117(Pt 10):2037-49. Epub 2004 Mar 30.

9.

Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption.

Saadoun S, Papadopoulos MC, Hara-Chikuma M, Verkman AS.

Nature. 2005 Apr 7;434(7034):786-92.

PMID:
15815633
10.

HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways.

Mehta VB, Besner GE.

Growth Factors. 2007 Aug;25(4):253-63.

PMID:
18092233
11.

Stimulatory effect of Cinnamomum cassia and cinnamic acid on angiogenesis through up-regulation of VEGF and Flk-1/KDR expression.

Choi DY, Baek YH, Huh JE, Ko JM, Woo H, Lee JD, Park DS.

Int Immunopharmacol. 2009 Jul;9(7-8):959-67. doi: 10.1016/j.intimp.2009.04.001. Epub 2009 Apr 6.

PMID:
19356742
12.

Identification of protein kinase D2 as a pivotal regulator of endothelial cell proliferation, migration, and angiogenesis.

Hao Q, Wang L, Zhao ZJ, Tang H.

J Biol Chem. 2009 Jan 9;284(2):799-806. doi: 10.1074/jbc.M807546200. Epub 2008 Nov 9.

13.

Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity.

Kawamura H, Li X, Harper SJ, Bates DO, Claesson-Welsh L.

Cancer Res. 2008 Jun 15;68(12):4683-92. doi: 10.1158/0008-5472.CAN-07-6577.

14.

Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin αvβ₃.

Lakshmikanthan S, Sobczak M, Chun C, Henschel A, Dargatz J, Ramchandran R, Chrzanowska-Wodnicka M.

Blood. 2011 Aug 18;118(7):2015-26. doi: 10.1182/blood-2011-04-349282. Epub 2011 Jun 2.

15.

Structural elements of kallistatin required for inhibition of angiogenesis.

Miao RQ, Chen V, Chao L, Chao J.

Am J Physiol Cell Physiol. 2003 Jun;284(6):C1604-13.

16.

In vitro angiogenic effects of pancreatic bile salt-dependent lipase.

Rebaï O, Le Petit-Thevenin J, Bruneau N, Lombardo D, Vérine A.

Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):359-64. Epub 2004 Nov 29.

17.

Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.

Chung TW, Kim SJ, Choi HJ, Kim KJ, Kim MJ, Kim SH, Lee HJ, Ko JH, Lee YC, Suzuki A, Kim CH.

Glycobiology. 2009 Mar;19(3):229-39. doi: 10.1093/glycob/cwn114. Epub 2008 Oct 30.

PMID:
18974200
18.

Angiopoietin-4 inhibits angiogenesis and reduces interstitial fluid pressure.

Olsen MW, Ley CD, Junker N, Hansen AJ, Lund EL, Kristjansen PE.

Neoplasia. 2006 May;8(5):364-72.

19.
20.

Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.

Jung MH, Lee SH, Ahn EM, Lee YM.

Carcinogenesis. 2009 Apr;30(4):655-61. doi: 10.1093/carcin/bgp039. Epub 2009 Feb 18.

PMID:
19228635

Supplemental Content

Support Center